Nationwide phase II randomized controlled trial of low-dose ibuprofen vs placebo for cancer-related cognitive impairment (CRCI) Meeting Abstract
| Authors: | Janelsins, M. C.; Gada, U.; Culakova, E.; Tejani, M. A.; Ahles, T.; Bautista, J.; O'Rourke, M. A.; Berenberg, J. L.; Le-Lindqwister, N.; McCormack, S. E.; Rasheed, H.; Morrow, G. R.; Mustian, K. M.; Peppone, L. J.; Mohile, S. G.; Dunne, R. F. |
| Abstract Title: | Nationwide phase II randomized controlled trial of low-dose ibuprofen vs placebo for cancer-related cognitive impairment (CRCI) |
| Meeting Title: | 2023 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 41 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2023 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2023-06-01 |
| Language: | English |
| DOI: | 10.1200/JCO.2023.41.16_suppl.12116 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting abstract: 12116 -- Meeting also presented virtually -- Source: Cinahl |
